KLG Earnings

KLG reported its earnings on 2025-08-05, showcasing a revenue of against an estimate of 633.97M, resulting in a 0% surprise. The EPS was 0, surpassing the expected 0.28 by 0% . The stock experienced a -0.3% price change on the earnings day and a -0.56% change over the next five days, reflecting market reactions to the results.

Following KLG's earnings announcement on 2025-08-05, the stock price moved by -0.30% on the day of the release. Over the subsequent five days, it saw a -0.56% change. Historically, KLG's stock price tends to shift by an average of -1.04% in the 10 days leading up to earnings and +3.79% in the 10 days following, providing insight into potential market.

For 2025/Q3, analysts estimate KLG’s annual revenue to reach 652.00M, while the EPS is projected at 0.29. These estimates reflect recent revisions, with revenue estimates revised Revenue No Change by 0% and EPS estimates No Change by 0% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between KLG's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were No Change by 0%, while EPS estimates moved No Change by 0% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, KLG's stock price typically moves by -1.04% in the 10 days before its earnings and +3.79% in the 10 days after. For the upcoming 2025/Q3 earnings, analysts expect an EPS of 0.29 and revenue of 652.00M.

The earnings call reveals a negative sentiment due to the EPS miss and lack of specific guidance on revenue, margins, or capex. The Q&A section highlights management's uncertainty about gross margin contraction and strategic plans, indicating possible instability. Despite optimism about health trends and potential brand revitalization, the absence of clear guidance and the EPS miss suggest a negative short-term reaction. Given the company's market cap, the stock price is likely to fall within the -2% to -8% range over the next two weeks.